The recent outbreak of the Wuhan Coronavirus is a topic that is at the forefront of all investors’ minds, particularly since information out of China is spotty and the numbers that are supplied by the Chinese government need to be met with high scrutiny. Many would wonder how the world’s second largest economy seemingly grinding to a halt would not cause a market sell off. The market reaction thus far has been relatively muted for several reasons:
The first reason is the derivative effects of the virus that the market is currently pricing in. The market is confident that China will be able to relatively contain the virus before it becomes a full-on Global Pandemic. From what we know now, the mortality rate from Coronavirus is relatively low. Figure 1, located below, plots the Coronavirus mortality statistics against similar outbreaks. As this is being written, only two deaths have been confirmed due to the virus outside of China. In the last few days several Chinese factories have announced that they are resuming operation and workers are returning to facilities. A minor detail that may soften the impact to U.S. companies’ inventories is that the virus outbreak has taken place over the Chinese New Year which is a period where factory output is predicted to be depressed. What the market is then pricing in is that once economic production resumes, economies will undergo a sharp increase in activity to make up for lost production due to the virus. Think of this as a “V-Shape” bounce on a graph.
Another derivative effect that the market is looking forward at is Central Bank stimulus. Just in the last few days the Peoples Bank of China injected 900 billion yuan (about 129 billion U.S. dollars) into the Chinese financial system. U.S. investors are predicting that the impact from the virus, and subsequent impact to GDP, will cause the Federal Reserve to continue to be accommodative via their own repurchase operations and possibly another rate cut. Many companies that have reported numbers in the last month have also given wide forward-guidance due to uncertainty from their supply chain status. This should dampen the shock that investors will get if subsequent numbers are materially impacted from their production or inventory drawdown...